Mastek Ltd
Mastek Ltd
Information TechnologyKey Fundamentals
MicrocapComputer Software & ConsultingInformation TechnologyInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Mastek Ltd insights
47 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
3- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 19.0%
- Company's median sales growth is 18.3% of last 10 years
Growth Rate
AI Analysis — Bull vs Bear
Mastek Ltd is a mid-cap IT services company with a market cap of ₹4,955 crore, trading at a PE of 12.5x. FY25 revenue grew 13.1% YoY to ₹3,455 crore with PAT rising 20.9% YoY to ₹376 crore, though Q4FY25 PAT declined 14% YoY despite 16.6% revenue growth. The stock has corrected 36% over the past year, reflecting concerns around margin compression and client concentration.
- FY25 PAT grew 20.9% YoY to ₹375.9 crore, demonstrating strong profit growth despite a challenging IT spending environment
- PE of 12.5x is significantly below mid-cap IT sector averages of 25-35x, offering valuation comfort if growth sustains
- 12-month order backlog reached $300.4 million, growing 13.5% YoY in USD terms and 24.4% YoY in INR terms, providing revenue visibility
- Compounded sales CAGR of 17% over 5 years and 22% over 10 years reflects consistent top-line execution with median sales growth of 18.3% over 10 years
- UK healthcare vertical (including NHS) grew over 100% YoY in Q4FY25, opening a large addressable market with UK government healthcare budget of £200 billion+
- Company has reduced debt and maintains a healthy dividend payout of 19%, with ₹16 per share final dividend declared for FY25
- Oracle business in North America grew over 50% YoY in FY25, diversifying revenue streams beyond UK government
- Compounded profit CAGR of 16% over 3 and 5 years demonstrates sustained earnings compounding alongside a 16% ROE
- Stock has declined 36% over the past year, significantly underperforming the broader market and IT index, reflecting loss of investor confidence
- Q4FY25 net profit fell 14.1% YoY to ₹81.1 crore despite 16.6% revenue growth, indicating margin pressure with EBITDA margins at 15.3% vs management's 17-19% target range
- Employee count declined from 5,500 to 4,800 (a ~13% reduction) driven by attrition without replacement, raising concerns about delivery capacity for growth
- Healthcare vertical accounts for 22% of revenue with significant NHS England concentration — NHS England's potential restructuring creates client-specific risk
- North America revenue saw an 8% sequential decline in Q4FY25 despite 16% YoY growth, showing volatility in a key growth geography
- TTM revenue growth has decelerated to 7% from 13% 3-year CAGR and 17% 5-year CAGR, suggesting a potential structural slowdown
- UK and Europe account for 45-55% of revenue historically, creating geographic concentration risk tied to UK government IT spending cycles
- 3-year stock CAGR of -6% and 5-year stock CAGR of -6% indicate the market has de-rated the stock despite continued earnings growth, suggesting a possible structural re-rating risk
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- UK public sector recognition Jul 3
Mastek featured in '100 Years in Monarchy and Democracy' publication for its UK contributions, highlighting a 30+ year partnership with the UK public sector.
- Yanbu Cement digital transformation Jun 29
Mastek partnered with Yanbu Cement to modernise operations using Industrial IoT, improving truck turnaround time by 2x and increasing topline revenue under Saudi Vision 2030.
- Q1FY27 earnings call July 22 Jul 3
Mastek will announce Q1FY27 results on July 21, 2026, with an earnings call scheduled for July 22 at 12:30 PM IST.
- Multiple investor meets late June Jun 25
Mastek scheduled virtual analyst meets with ICICI Securities (June 30, 4 PM), Incred Capital (June 30, 2 PM), and an institutional investor meet on June 25 at 4 PM IST.
TL;DR: Mastek shows steady business development with a notable Middle East IoT win and continued UK public sector strength. No visible headwinds in recent news flow. The company is actively engaging institutional investors ahead of Q1FY27 results on July 21, suggesting confidence in upcoming numbers. Trend appears stable with potential upside from new geography wins.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 725 | 766 | 784 | 780 | 813 | 867 | 870 | 905 | 915 | 940 | 906 | 938 | 985 |
| Expenses | 598 | 642 | 651 | 655 | 689 | 724 | 729 | 767 | 777 | 795 | 754 | 787 | 834 |
| Operating Profit | 127 | 123 | 134 | 125 | 124 | 143 | 141 | 139 | 137 | 146 | 152 | 151 | 151 |
| OPM % | 18% | 16% | 17% | 16% | 15% | 16% | 16% | 15% | 15% | 15% | 17% | 16% | 15% |
| Other Income | 2 | 1 | 3 | 5 | 4 | 17 | 13 | -5 | 11 | 15 | 14 | 0 | 12 |
| Interest | 9 | 13 | 13 | 9 | 9 | 11 | 12 | 10 | 9 | 9 | 7 | 7 | 7 |
| Depreciation | 20 | 21 | 22 | 27 | 20 | 20 | 17 | 19 | 18 | 18 | 18 | 18 | 18 |
| PBT | 100 | 90 | 102 | 94 | 99 | 129 | 126 | 106 | 121 | 134 | 141 | 125 | 138 |
| Tax % | 27% | 28% | 24% | -1% | 28% | 0% | 25% | 23% | 24% | 27% | 23% | 15% | 24% |
| Net Profit | 74 | 65 | 78 | 94 | 72 | 129 | 95 | 81 | 92 | 97 | 108 | 106 | 106 |
| EPS in Rs | 22.91 | 20.5 | 24.56 | 29.85 | 23.18 | 41.68 | 30.67 | 26.2 | 29.75 | 31.46 | 34.96 | 34.24 | 34.15 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,013 | 527 | 560 | 817 | 1,033 | 1,071 | 1,722 | 2,184 | 2,563 | 3,055 | 3,455 | 3,699 | 3,769 |
| Expenses | 965 | 509 | 515 | 718 | 902 | 916 | 1,357 | 1,721 | 2,108 | 2,546 | 2,909 | 3,113 | 3,170 |
| Operating Profit | 47 | 18 | 45 | 100 | 132 | 156 | 364 | 463 | 456 | 509 | 546 | 586 | 600 |
| OPM % | 4.7% | 3.5% | 8% | 12% | 13% | 15% | 21% | 21% | 18% | 17% | 16% | 16% | 16% |
| Other Income | 14 | 15 | 12 | 21 | 25 | 17 | 28 | 36 | 64 | 12 | 30 | 40 | 42 |
| Interest | 1 | 0 | 4 | 6 | 6 | 4 | 8 | 8 | 25 | 44 | 42 | 32 | 30 |
| Depreciation | 37 | 16 | 15 | 19 | 17 | 25 | 45 | 43 | 67 | 90 | 75 | 73 | 73 |
| PBT | 22 | 16 | 39 | 96 | 133 | 144 | 339 | 448 | 427 | 386 | 459 | 521 | 539 |
| Tax % | 20% | 17% | 17% | 27% | 24% | 21% | 26% | 26% | 27% | 19% | 18% | 22% | — |
| Net Profit | 18 | 14 | 32 | 70 | 101 | 114 | 252 | 333 | 310 | 311 | 376 | 404 | 418 |
| EPS in Rs | 7.86 | 5.97 | 13.86 | 29.53 | 42.33 | 44.82 | 82.97 | 98.32 | 95.99 | 97.36 | 122 | 130 | 135 |
| Div. Payout % | 32% | 42% | 25% | 20% | 20% | 18% | 17% | 19% | 20% | 20% | 19% | 18% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 15 | 15 | 16 |
| Reserves | 585 | 308 | 457 | 537 | 704 | 778 | 846 | 1,056 | 1,668 | 2,072 | 2,447 | 2,976 |
| Borrowings | 29 | 0 | 66 | 70 | 70 | 335 | 273 | 203 | 404 | 519 | 583 | 438 |
| Other Liabilities | 207 | 108 | 170 | 202 | 179 | 763 | 1,146 | 1,193 | 1,024 | 1,045 | 803 | 879 |
| Total Liabilities | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 | 4,309 |
| Fixed Assets | 279 | 66 | 180 | 179 | 167 | 857 | 807 | 841 | 1,740 | 1,950 | 1,818 | 1,939 |
| CWIP | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 4 | 7 | 1 | 2 | 2 |
| Investments | 54 | 50 | 274 | 284 | 396 | 276 | 234 | 66 | 69 | 94 | 178 | 234 |
| Other Assets | 498 | 312 | 251 | 356 | 401 | 754 | 1,235 | 1,556 | 1,296 | 1,607 | 1,851 | 2,135 |
| Total Assets | 832 | 428 | 705 | 821 | 966 | 1,888 | 2,277 | 2,467 | 3,111 | 3,652 | 3,848 | 4,309 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 59 | 32 | 43 | 65 | 75 | 184 | 287 | 273 | 108 | 420 | 395 | 542 |
| Investing | -28 | -84 | -127 | -18 | -54 | -262 | 218 | -26 | -719 | -249 | -259 | -66 |
| Financing | 22 | -4 | 65 | -7 | -16 | 205 | -118 | -128 | 93 | 2 | -57 | -300 |
| Net Cash Flow | 53 | -57 | -20 | 40 | 5 | 127 | 387 | 119 | -519 | 173 | 80 | 176 |
| Free Cash Flow | 10 | 20 | 31 | 50 | 60 | 169 | 276 | 237 | 126 | 391 | 376 | 515 |
| CFO/OP | 121 | 199 | 102 | 74 | 80 | 149 | 92 | 83 | 53 | 104 | 95 | 121 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 | 57 |
| Cash Conversion Cycle | 48 | 67 | 55 | 78 | 74 | 108 | 79 | 73 | 72 | 67 | 78 | 57 |
| Working Capital Days | 25 | 38 | 29 | 15 | 38 | 4 | -35 | -20 | 34 | -1 | 28 | 42 |
| ROCE % | 5% | 3% | 10% | 17% | 19% | 16% | 26% | 32% | 23% | 18% | 17% | 18% |
Documents
Frequently Asked Questions about Mastek Ltd
What does Mastek Ltd do?
Where is Mastek Ltd (MASTEK) listed?
Which sector does Mastek Ltd belong to?
What is the market capitalisation of Mastek Ltd?
What is the PE ratio of Mastek Ltd?
What is the 52-week high and low of Mastek Ltd?
Does Mastek Ltd pay dividends?
What is the Return on Equity (ROE) of Mastek Ltd?
How can I research Mastek Ltd on Tapetide?
Company Information
Established in 1982, Mastek is a provider of vertically-focused enterprise technology solutions. Having its presence in IT industry for almost 4 decades, Mastek Ltd has evolved from an IT solutions provider to Digital transformation partner.[1]